Vimta Labs Limited
VIMTALABS · 524394 · Healthcare · Healthcare Research, Analytics & Technology
Rs 617-16.2 (-2.56%)
- Market cap
- Rs 1,371 Cr
- P/E
- 46.29x
- P/B
- 4.00x
- 52W high / low
- Rs 902.65 / Rs 376.05
P/E, P/B and ROE are inconsistent: ROE x P/E = 9.45 but P/B = 4.00 (> 25% apart); one input is likely on a different basis.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Indegene Limited | Rs 555.8 | Rs 13,367 Cr | Rs 3,892 Cr | Rs 401 Cr | 33.26x | 10.39% |
| Suven Life Sciences Limited | Rs 342.35 | Rs 9,038 Cr | Rs 29.7 Cr | Rs -352.4 Cr | — | -100.50% |
| Vimta Labs LimitedThis company | Rs 617 | Rs 1,371 Cr | Rs 339 Cr | Rs 61.4 Cr | 46.29x | 20.41% |
| TAKE Limited | Rs 23.76 | Rs 351 Cr | Rs 92.5 Cr | Rs 12.8 Cr | 60.92x | 49.76% |
| Novelix Pharmaceuticals Ltd | Rs 76.9 | Rs 184 Cr | Rs 6.7 Cr | Rs -0.6 Cr | — | -1.98% |
| Bilcare Limited | Rs 76.81 | Rs 181 Cr | Rs 799 Cr | Rs -13.3 Cr | — | 2.33% |
| Jeevan Scientific Technology Ltd | Rs 80.25 | Rs 161 Cr | Rs 71.8 Cr | Rs 5.1 Cr | 27.77x | 8.40% |
| Median | Rs 555.8 | Rs 1,371 Cr | Rs 339 Cr | Rs 61.4 Cr | 33.26x | 10.39% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Loading stock details